Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The ABNF Journal : Official Journal of the Association of Black Nursing Faculty in Higher Education, Inc|January 5, 2002
Testing a life-style risk model in an Afro-American populationM T Beard
Nursing Research|March 1, 1975
The efficacy of group therapy by nurses for hospitalized patientsM T Beard, P Y Scott
Holistic Nursing Practice|July 18, 2002
The grief of parents of murdered children: a suggested model for interventionM Schmidt Kashka, M T Beard
The ABNF Journal : Official Journal of the Association of Black Nursing Faculty in Higher Education, Inc|March 1, 1995
Research methodology. Part I: Understanding correlational analysisM T Beard, K A Edwards, D Marshall
The ABNF Journal : Official Journal of the Association of Black Nursing Faculty in Higher Education, Inc|July 1, 1995
Research methodology: Part II, Essentials of factor analysisM T Beard, K Edwards, D Marshall, et al.
The ABNF Journal : Official Journal of the Association of Black Nursing Faculty in Higher Education, Inc|December 5, 1997
Advances in meta-analysis as a research methodM T Beard, E L Curry, K Edwards, et al.
The ABNF Journal : Official Journal of the Association of Black Nursing Faculty in Higher Education, Inc|November 1, 1995
Research methodology. Part III: understanding multiple correlation analysis and multiple regressionM T Beard, K A Edwards, E L Curry, et al.
The ABNF Journal : Official Journal of the Association of Black Nursing Faculty in Higher Education, Inc|January 1, 1996
Research methodology. Part IV: Understanding canonical correlation analysisM T Beard, K A Edwards, E L Curry, et al.
Sarcoma|June 4, 2008
Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue SarcomasM von Mehren, S P Balcerzak, A S Kraft, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinomaM von Mehren, P Arlen, J Gulley, et al.
Pageof 1